Page 93 - ARNM-3-2
P. 93

Advances in Radiotherapy
            & Nuclear Medicine                                               Radiotherapy in node-positive bladder cancer



               alternative to radical cystectomy in patients with clinically   combined with immune checkpoint inhibition for locally
               node-positive nonmetastatic bladder cancer.  J  Clin  Oncol.   advanced urothelial bladder cancer-a review.  Cancers
               2023;41(27):4406-4415.                             (Basel). 2022;14(1):38.
               doi: 10.1200/JCO.23.00725                          doi: 10.3390/cancers14010038
            19.  Fonteyne V, Dirix P, Van Praet C, et al. Adjuvant radiotherapy   23.  Ghatalia P, Plimack ER. Adding a fourth modality to
               after radical cystectomy for patients with high-risk muscle-  trimodal therapy for muscle-invasive bladder cancer.  Eur
               invasive bladder cancer: Results of a multicentric phase II   Urol. 2022;82(5):527-528.
               trial. Eur Urol Focus. 2022;8(5):1238-1245.
                                                                  doi: 10.1016/j.eururo.2022.08.017
               doi: 10.1016/j.euf.2021.11.004
                                                               24.  Wilkins A, Ost P, Sundahl N. Is there a benefit of combining
            20.  Murthy V, Maitre P, Singh M, et al. Study protocol of the   immunotherapy and radiotherapy in bladder cancer? Clin
               bladder adjuvant radiotherapy (BART) trial: A randomised   Oncol (R Coll Radiol). 2021;33(6):407-414.
               phase III trial of adjuvant radiotherapy following
               cystectomy in bladder cancer.  Clin Oncol  (R Coll Radiol).      doi: 10.1016/j.clon.2021.02.014
               2023;35(9):e506-e515.                           25.  Swinton M, Devi A, Song YP, Hoskin P, Choudhury A.
               doi: 10.1016/j.clon.2023.04.010                    Beyond surgery: Bladder preservation and the role of
                                                                  systemic  treatment  in  localised  muscle-invasive  bladder
            21.  Vale  CL.  Neoadjuvant  chemotherapy in  invasive  bladder   cancer. World J Urol. 2024;42(1):210.
               cancer: Update of a systematic review and meta-analysis of
               individual patient data: Advanced bladder cancer (ABC)      doi: 10.1007/s00345-024-04892-8
               meta-analysis collaboration. Eur Urol. 2005;48(2):202-206.  26.  Matuszczak M, Kiljańczyk A, Salagierski M. A  liquid
               doi: 10.1016/j.eururo.2005.04.006                  biopsy in bladder cancer-the current landscape in urinary
                                                                  biomarkers. Int J Mol Sci. 2022;23(15):8597.
            22.  Van Hattum JW, De Ruiter BM, Oddens JR, Hulshof MCC,
               De Reijke TM, Bins AD. Bladder-sparing chemoradiotherapy      doi: 10.3390/ijms23158597














































            Volume 3 Issue 2 (2025)                         85                        doi: 10.36922/ARNM025090009
   88   89   90   91   92   93   94   95   96   97   98